The Nasdaq Composite has experienced a decline for four consecutive days, with notable movements in individual stocks. SpaceX's IPO, priced at $135, saw shares close at $153, peaking at $225.64 earlier this month. Analysts are divided on the stock, with a consensus price target of $242.57.
CVS has gained significant attention, with a 45% increase over three months and a new high of $104.66, supported by strong analyst ratings. In contrast, the 'Magnificent Seven' tech stocks, including Tesla and Meta Platforms, have all seen declines from their recent highs, with Tesla down 25% and Meta down 32%.
The article also notes sector performance, with healthcare and utilities showing gains, while tech and communications lag behind. Upcoming economic data, specifically the University of Michigan's consumer sentiment report, is anticipated to provide further market insights